Target intelligence / Profile preview

Colonic microbiota fermentation to short-chain fatty acids

Molecular classification
Other (metabolic process, not a discrete molecule or receptor)
01

Overview

Colonic microbiota fermentation to short-chain fatty acids refers to the metabolic activity by which the dense population of microorganisms residing in the colon ferment undigested carbohydrates and proteins that escape absorption in the small intestine. This anaerobic process produces **short-chain fatty acids** (SCFAs), primarily acetate, propionate, and butyrate, which account for 90–95% of total SCFAs present in the colon. These metabolites play crucial roles in shaping the gut environment by lowering pH, supporting energy metabolism for both host cells and other microbes, regulating immune responses—such as promoting regulatory T cell differentiation—and influencing systemic physiological processes including appetite control and energy homeostasis. The composition and function of colonic microbiota—and thus SCFA production—are strongly influenced by diet. While these processes have significant implications for health and disease states such as inflammation, metabolic syndrome, neurological disorders via gut-brain communication pathways, "colonic microbiota fermentation to short-chain fatty acids" is a **metabolic pathway**, not a single molecular therapeutic target like an enzyme or receptor. Because it describes a biological process rather than an individual molecule or receptor typically considered "druggable," it is **not classified as a canonical therapeutic target** under standard pharmacological definitions. There are no direct drugs targeting the process itself; some interventions like prebiotics/probiotics modulate this pathway indirectly. Drugs do not directly target this process; dietary interventions and microbiome modulators can influence it. SCFA levels in stool or blood may serve as biomarkers for colonic fermentation activity but are not specific molecular markers. No direct safety concerns related to targeting this process as a drug target; however, excessive protein fermentation can produce toxic metabolites such as ammonia and phenols.

Other names
Gut microbiota fermentation to SCFAIntestinal microbial fermentation to short-chain fatty acidsMicrobial production of SCFA in colon
02

Biological functions

Energy metabolismRegulation of gut environment (pH, microbial diversity)Host signaling modulationImmune regulationMaintenance of colonic health
03

Disease associations

Inflammation (e.g., inflammatory bowel disease)Metabolic disorders (obesity, diabetes)Neurological conditions (via gut-brain axis)Other gastrointestinal diseases

Beyond the preview

Go deeper on Colonic microbiota fermentation to short-chain fatty acids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic microbiota fermentation to short-chain fatty acids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call